======= FAM111A ======= == Gene Information == * **Official Symbol**: FAM111A * **Official Name**: family with sequence similarity 111 member A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=63901|63901]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96PZ2|Q96PZ2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FAM111A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FAM111A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615292|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is cell-cycle regulated, and has nuclear localization. The C-terminal half of the protein shares homology with trypsin-like peptidases and it contains a PCNA-interacting peptide (PIP) box, that is necessary for its co-localization with proliferating cell nuclear antigen (PCNA). Reduced expression of this gene resulted in DNA replication defects, consistent with the demonstrated role for this gene in Simian Virus 40 (SV40) viral replication. Mutations in this gene have been associated with Kenny-Caffey syndrome (KCS) type 2 and the more severe osteocraniostenosis (OCS, also known as Gracile Bone Dysplasia), both characterized by short stature, hypoparathyroidism, bone development abnormalities, and hypocalcemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]. * **UniProt Summary**: Chromatin-associated protein required for PCNA loading on replication sites. Promotes S-phase entry and DNA synthesis (PubMed:24561620). May directly function at replication forks, explaining why Simian virus 40 (SV40) interacts with FAM111A to overcome host range restriction (PubMed:23093934). {ECO:0000269|PubMed:23093934, ECO:0000269|PubMed:24561620}. No Pfam Domain information is available for this gene. |negative regulation of viral genome replication| |negative regulation of viral life cycle| |regulation of viral genome replication| |negative regulation of viral process| |chromatin| |fibrillar center| |regulation of viral life cycle| |defense response to virus| |regulation of viral process| |DNA replication| |negative regulation of multi-organism process| |regulation of symbiosis, encompassing mutualism through parasitism| |response to virus| |viral process| |regulation of multi-organism process| |symbiotic process| |interspecies interaction between organisms| |defense response to other organism| |immune effector process| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp280|Daidzin 10μM R06 exp280]]|-1.93| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|-1.92| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|1.72| |[[:results:exp271|CCT251545 0.2μM R06 exp271]]|1.77| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|1.92| |[[:results:exp247|UM0130462 0.025 to 0.035μM day4 R05 exp247]]|2.08| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|4.08| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.588| |[[:human genes:p:prim1|PRIM1]]|0.421| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14270 * **Expression level (log2 read counts)**: 7.86 {{:chemogenomics:nalm6 dist.png?nolink |}}